Showing results (101-110 of 219) with videos related to

Sort By:
Pageof 22
Transplantation Proceedings|December 10, 2013
Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantationS Alvarez, C Suazo, A Boltansky, et al.
European Journal of Immunology|January 1, 1995
Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonistS Gillessen, D Carvajal, P Ling, et al.
British Journal of Cancer|August 23, 2022
Clinical and genomic correlates of imatinib response in melanomas with KIT alterationsSeungyeon Jung, Emma Armstrong, Alexander Z Wei, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumorsBen Tran, Richard D Carvajal, Aurelien Marabelle, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 20, 2009
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancerRichard D Carvajal, Archie Tse, Manish A Shah, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Frontiers in Oncology|January 6, 2022
Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current EvidenceConnor J Stonesifer, A Reza Djavid, Joseph M Grimes, et al.
Cancer|September 5, 2014
Clinico-morphological features of BRAF inhibition-induced proliferative skin lesions in cancer patientsViswanath Reddy Belum, Alyx C Rosen, Natalia Jaimes, et al.
Journal of Academic Ophthalmology (2017)|June 30, 2023
Perceived Barriers to Increasing Diversity within Oculofacial Plastic SurgeryJohsias A Maru, Nicole D Carvajal, Alejandra G de Alba Campomanes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2012
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trialJason J Luke, David R D'Adamo, Mark A Dickson, et al.
Pageof 22